banner
PLL agent, Chondroitin sulfate-poly-L-lysine, Purity ≥95%

Cat. No.: X25-05-YM063

PLL agent, Chondroitin sulfate-poly-L-lysine, Purity ≥95%

Synonym: Poly-L-lysine-chondroitin sulfate; PLL-chondroitin sulfate; Chondroitin sulfate-PLL

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
PLL-chondroitin sulfate polylysine composite forms stable coacervates through charge interactions, combining cationic polymer's nucleic acid binding with chondroitin's biocompatibility.
Glycan Name
Chondroitin sulfate
Glycan Structure
The glycan structure of chondroitin sulfate (CS) is a sulfated glycosaminoglycan (GAG) composed of repeating disaccharide units. Each unit consists of: N-acetyl-D-galactosamine (GalNAc) (β1→4 linked) D-glucuronic acid (GlcA) (β1→65 linked)
Source
Chemical synthesis
Functional Group
PLL
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Chondroitin sulfate-poly-L-lysine can be used for its potential to engineer acrylate-functionalized polymers for UV-crosslinkable hydrogels.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0